v3.25.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended
May 03, 2025
May 04, 2024
Cash flows from operating activities:    
Net loss $ (11,661) $ (46,483)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 49,365 49,587
Amortization of debt discounts and issuance costs 1,246 1,218
Provision for deferred taxes (9,218) (13,365)
Equity-based compensation 9,420 17,434
Impairments, write-offs and losses on sale of fixed and other assets 446 3,508
Income from equity method investees (4,610) (4,886)
Amounts reclassified out of accumulated other comprehensive loss (212) (1,129)
Non-cash operating lease costs 102,132 103,637
Other non-operating loss   2,665
Changes in assets and liabilities:    
Receivables 4,229 2,987
Merchandise inventories 7,857 3,076
Prepaid expenses and other assets (1,673) (4,511)
Accounts payable and book overdrafts (19,028) (19,538)
Accrued salaries and employee benefits (51,130) (5,474)
Accrued expenses and other liabilities 12,426 5,902
Operating lease liabilities (103,780) (104,181)
Other long-term liabilities (1,263) 1,139
Net cash used in operating activities (15,454) (8,414)
Cash flows from investing activities:    
Cash paid for fixed assets (28,412) (32,641)
Cash paid for acquisitions, net of cash acquired   (100)
Proceeds from investments   998
Proceeds from sale of assets 1,279  
Net cash used in investing activities (27,133) (31,743)
Cash flows from financing activities:    
Borrowings under long-term debt agreements   173,000
Repayments of long-term debt   (173,000)
Debt refinancing costs   (2,955)
Payments for finance lease liabilities (1,143) (1,444)
Proceeds from employee stock purchase plan and stock option exercises 967 830
Tax withholdings on stock-based awards (158) (2,059)
Net cash used in financing activities (334) (5,628)
Net decrease in cash, cash equivalents and restricted cash (42,921) (45,785)
Cash, cash equivalents and restricted cash at beginning of period 181,665 136,649
Cash, cash equivalents and restricted cash at end of period 138,744 90,864
Supplemental cash flow disclosures:    
Interest paid, net 31,112 34,357
Income taxes paid 630 1,282
Supplemental non-cash investing and financing activities disclosure:    
Accounts payable and accrued expenses for capital expenditures $ 13,010 $ 14,541